Technical Analysis for ICLR - ICON plc

Grade Last Price % Change Price Change
C 332.51 -0.67% -2.25
ICLR closed down 0.67 percent on Monday, March 18, 2024, on 65 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Down

Date Alert Name Type % Chg
Hammer Candlestick Bullish -0.67%
MACD Bearish Signal Line Cross Bearish -0.35%
Overbought Stochastic Strength -0.30%
Overbought Stochastic Strength -1.73%
1,2,3 Pullback Bullish Bullish Swing Setup 0.04%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.04%
Overbought Stochastic Strength 0.04%
Outside Day Range Expansion -0.64%
Overbought Stochastic Strength -0.64%
New 52 Week Closing High Bullish -2.20%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 10 hours ago
60 Minute Opening Range Breakdown about 11 hours ago
60 Minute Opening Range Breakout about 13 hours ago
10 DMA Resistance about 14 hours ago
Hammer Candlestick Entry about 14 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ICON plc Description

ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in Ireland, the United States, and rest of Europe. It operates through two segments, Clinical Research and Central Laboratory. The Clinical Research segment specializes in strategic development, management, and analysis of programs that support various stages of clinical development process from compound selection to Phase I to IV clinical studies. Its clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety monitoring, clinical data management, interactive voice response, electronic patient reported outcomes, medical reporting, patient registries, outcomes research, and health economics. This segment's clinical research services also comprise marker access and commercialization services, strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynamic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, pricing and market access consulting, medical imaging, contract staffing, and electronic endpoint adjudication. The Central Laboratory segment offers various laboratory services, such as sample analyses, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development. ICON Public Limited Company was founded in 1990 and is headquartered in Dublin, Ireland.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Biology Clinical Development Pharmacology Clinical Research Clinical Trial Medical Imaging Biomarkers Medical Research Data Collection Recruitment Microbiology Clinical Pharmacology Laboratory Services Immunoassay Contract Research Organizations Flow Cytometry Interactive Voice Response Patient Safety Health Economics Statistical Analysis Clinical Data Management Contract Research Organization

Is ICLR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 344.77
52 Week Low 181.92
Average Volume 581,470
200-Day Moving Average 261.55
50-Day Moving Average 290.00
20-Day Moving Average 324.42
10-Day Moving Average 335.06
Average True Range 9.01
RSI (14) 66.78
ADX 51.04
+DI 32.45
-DI 13.48
Chandelier Exit (Long, 3 ATRs) 317.73
Chandelier Exit (Short, 3 ATRs) 304.25
Upper Bollinger Bands 355.30
Lower Bollinger Band 293.54
Percent B (%b) 0.63
BandWidth 19.03
MACD Line 13.29
MACD Signal Line 14.65
MACD Histogram -1.3552
Fundamentals Value
Market Cap 27.37 Billion
Num Shares 82.3 Million
EPS 6.21
Price-to-Earnings (P/E) Ratio 53.54
Price-to-Sales 2.86
Price-to-Book 2.56
PEG Ratio 2.66
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 341.50
Resistance 3 (R3) 342.36 340.24 340.00
Resistance 2 (R2) 340.24 337.95 339.80 339.50
Resistance 1 (R1) 336.37 336.53 335.31 335.51 339.00
Pivot Point 334.25 334.25 333.72 333.81 334.25
Support 1 (S1) 330.38 331.96 329.32 329.52 326.02
Support 2 (S2) 328.26 330.54 327.82 325.52
Support 3 (S3) 324.39 328.26 325.02
Support 4 (S4) 323.53